Cargando…

Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines

BACKGROUND: Molecular adjuvants are a promising method to enhance virus-specific immune responses and protect against HIV-1 infection. Immune activation by ligands for receptors such as CD40 can induce dendritic cell activation and maturation. Here we explore the incorporation of two CD40 mimics, Ep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Sachin, Termini, James M, Niu, Liguo, Kanagavelu, Saravana K, Rahmberg, Andrew R, Kornbluth, Richard S, Evans, David T, Stone, Geoffrey W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118346/ https://www.ncbi.nlm.nih.gov/pubmed/21592361 http://dx.doi.org/10.1186/1742-4690-8-39

Ejemplares similares

Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion
por: Termini, James M., et al.
Publicado: (2017)

HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity
por: Kanagavelu, Saravana, et al.
Publicado: (2014)

Evaluation of Latent Membrane Protein 1 as a novel vaccine adjuvant
por: Termini, JM, et al.
Publicado: (2012)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors
por: Gupta, Sachin, et al.
Publicado: (2016)

Utilizing a TLR5-Adjuvanted Cytomegalovirus as a Lentiviral Vaccine in the Nonhuman Primate Model for AIDS
por: Deere, Jesse D., et al.
Publicado: (2016)

Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
por: Yang, Dongchang, et al.
Publicado: (2011)

Multimeric forms of 4-1BBL as stimulators of T cells for adoptive immunotherapy
por: Kornbluth, Richard S, et al.
Publicado: (2014)

Envelope Determinants of Equine Lentiviral Vaccine Protection
por: Craigo, Jodi K., et al.
Publicado: (2013)

Recent Advances in Lentiviral Vaccines for HIV-1 Infection
por: Norton, Thomas D., et al.
Publicado: (2016)

Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides
por: Steinstraesser, Lars, et al.
Publicado: (2005)

Control of HIV replication by a novel constitutively active ‘super-PRR’
por: Gupta, S, et al.
Publicado: (2012)

Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification
por: Labisch, Jennifer Julia, et al.
Publicado: (2023)

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands
por: Grossmann, Claudius, et al.
Publicado: (2009)

Systemic Activation of TLR3-Dependent TRIF Signaling Confers Host Defense against Gram-Negative Bacteria in the Intestine
por: Ruiz, Jose, et al.
Publicado: (2016)

Lysophosphatidylcholine as an adjuvant for lentiviral vector mediated gene transfer to airway epithelium: effect of acyl chain length
por: Cmielewski, Patricia, et al.
Publicado: (2010)

Corrigendum: Recent Advances in Lentiviral Vaccines for HIV-1 Infection
por: Norton, Thomas D., et al.
Publicado: (2016)

Lentiviral Vectors as a Vaccine Platform against Infectious Diseases
por: Nemirov, Kirill, et al.
Publicado: (2023)

Production of lentiviral vectors
por: Merten, Otto-Wilhelm, et al.
Publicado: (2016)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
por: Morante, Valeria, et al.
Publicado: (2021)

TIR-domain-containing adapter-inducing interferon-β (TRIF) regulates Th17-mediated intestinal immunopathology in colitis
por: Kanagavelu, S, et al.
Publicado: (2015)

Outer membrane proteins of Salmonella typhimurium as an adjuvant in rabies vaccine
por: Negm, Iman Ibrahim, et al.
Publicado: (2021)

Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic Membrane
por: Hen, Gideon, et al.
Publicado: (2012)

Impact of the Membrane Structure of the Stationary Phase on Steric Exclusion Chromatography (SXC) of Lentiviral Vectors
por: Labisch, Jennifer J., et al.
Publicado: (2023)

Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies
por: Buck, Amanda M., et al.
Publicado: (2023)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Clinical use of lentiviral vectors
por: Milone, Michael C., et al.
Publicado: (2018)

Roles for endocytosis in lentiviral replication
por: Marsh, Mark, et al.
Publicado: (1997)

Special Issue “Lentiviral Vectors”
por: Takeuchi, Yasuhiro
Publicado: (2022)

Protective Antiviral Immunity Conferred by a Nonintegrative Lentiviral Vector-Based Vaccine
por: Coutant, Frédéric, et al.
Publicado: (2008)

Design and development of a new lentiviral based anti-HIV therapeutic vaccine
por: Rodriguez, M, et al.
Publicado: (2012)

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy
por: Craigo, JK, et al.
Publicado: (2009)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018)

In vitro and in vivo gene delivery using a lentiviral vector
por: Gouze-Decaris, E, et al.
Publicado: (2001)

Correction: Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic Membrane
por: Hen, Gideon, et al.
Publicado: (2012)

Correction: Gene Transfer to Chicks Using Lentiviral Vectors Administered via the Embryonic Chorioallantoic Membrane
por: Hen, Gideon, et al.
Publicado: (2015)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses
por: Nemirov, Kirill, et al.
Publicado: (2023)

Rev-dependent lentiviral expression vector
por: Wu, Yuntao, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_fnf33epfo05dr41gs860dt5p5n